e-learning
resources
European Respiratory Review
2015
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Influence of N-acetylcysteine on chronic bronchitis or COPD exacerbations: a meta-analysis
Cazzola Mario, Calzetta Luigino, Page Clive, Jardim Josè, Chuchalin Alexander G., Rogliani Paola, Gabriella Matera Maria
Source:
Eur Respir Rev 2015; 24: 451-461
Journal Issue:
September
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Cazzola Mario, Calzetta Luigino, Page Clive, Jardim Josè, Chuchalin Alexander G., Rogliani Paola, Gabriella Matera Maria. Influence of N-acetylcysteine on chronic bronchitis or COPD exacerbations: a meta-analysis. Eur Respir Rev 2015; 24: 451-461
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
N-acetylcysteine for the treatment of acute exacerbations of COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 374s
Year: 2002
The efficacy and safety of inhaled fluimucil-antibiotic-IT in the treatment of exacerbations of COPD and chronic bronchitis with bronchiectasis
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013
Clinical effectiveness of nebulized budesonide in the treatment of acute asthma and exacerbations of chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2001; 18: Suppl. 33, 146s
Year: 2001
Long term treatment with n-acetylcysteine reduces exacerbations in moderate chronic obstructive pulmonary disease
Source: International Congress 2016 – Pharmacological management of COPD
Year: 2016
Mechanism by which inhaled bronchodilators prevent exacerbations in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics
Year: 2013
Changes in bronchial inflammation during acute exacerbations of chronic bronchitis
Source: Eur Respir J 2001; 17: 1112-1119
Year: 2001
Evaluation of COPD exacerbations using the EXACT-U
Source: Annual Congress 2010 - COPD exacerbation
Year: 2010
Influence of bronchiectasis in COPD exacerbations caused by
pseudomonas aeruginosa
Source: Annual Congress 2009 - Respiratory infection caused by Pseudomonas aeruginosa
Year: 2009
Impact of Bronchial Rheoplasty on exacerbations in chronic bronchitis: a US feasibility study
Source: Virtual Congress 2021 – Pharmacology of airway diseases: clinical and laboratory studies
Year: 2021
Acute exacerbations of COPD
Source: Eur Respir Monogr 2016; 74: 48-65
Year: 2016
Impact of mucolytic treatment on COPD exacerbations
Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation
Year: 2013
Management of acute COPD exacerbations
Source: Annual Congress 2013 –Recommendations from the ERS/ATS Guideline on COPD Exacerbation Prevention
Year: 2013
Impact of halotherapy on COPD exacerbations
Source: International Congress 2019 – COPD treatment: cohorts and real-world studies
Year: 2019
Acute exacerbations of COPD: The influence of comorbidities and chronic medication on mortality and exacerbation rate
Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction
Year: 2015
Acute exacerbations of chronic obstructive pulmonary disease: Is it acute exacerbations of chronic cardiopulmonary disease?
Source: International Congress 2014 – Comorbidities
Year: 2014
Defining the contribution of emphysema and chronic bronchitis in COPD patients
Source: Eur Respir J 2003; 22: Suppl. 45, 539s
Year: 2003
Antibiotics in acute exacerbation of asthma and COPD
Source: Eur Respir Monogr 2017; 75: 150-158
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept